These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Increased cardiovascular risk associated with diabetes in Dallas County. Das SR; Vaeth PA; Stanek HG; de Lemos JA; Dobbins RL; McGuire DK Am Heart J; 2006 May; 151(5):1087-93. PubMed ID: 16644340 [TBL] [Abstract][Full Text] [Related]
46. [A woman with anginal symptoms and normal coronary arteries]. Asselman MA; Westra SW; Verheugt FW Ned Tijdschr Geneeskd; 2008 Oct; 152(40):2155-9. PubMed ID: 18953775 [TBL] [Abstract][Full Text] [Related]
47. Treatment of the dyslipidemia of insulin resistance. Smith DA Med Clin North Am; 2007 Nov; 91(6):1185-210, x. PubMed ID: 17964916 [TBL] [Abstract][Full Text] [Related]
48. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up. Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645 [TBL] [Abstract][Full Text] [Related]
49. Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy. Polonsky TS; Davidson MH Am J Cardiol; 2008 Apr; 101(8A):27B-35B. PubMed ID: 18375238 [TBL] [Abstract][Full Text] [Related]
50. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. Thielmann M; Neuhäuser M; Marr A; Jaeger BR; Wendt D; Schuetze B; Kamler M; Massoudy P; Erbel R; Jakob H J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1143-9. PubMed ID: 17976441 [TBL] [Abstract][Full Text] [Related]
51. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management. Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582 [TBL] [Abstract][Full Text] [Related]
52. Treating dyslipidaemia in the setting of diabetes mellitus and cardiovascular disease: another focus. Tahrani AA Int J Clin Pract; 2006 Nov; 60(11):1515; author reply 1515-6. PubMed ID: 17073848 [No Abstract] [Full Text] [Related]
53. Lipid management in the geriatric patient. Nair AP; Darrow B Endocrinol Metab Clin North Am; 2009 Mar; 38(1):185-206. PubMed ID: 19217519 [TBL] [Abstract][Full Text] [Related]
54. Fenofibrate set to benefit from new research on its active metabolite, fenofibric acid. Cardiovasc J Afr; 2008; 19(3):171-2. PubMed ID: 18568186 [No Abstract] [Full Text] [Related]
55. Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Ridker PM Circulation; 2003 Sep; 108(12):e81-5. PubMed ID: 14504253 [No Abstract] [Full Text] [Related]
56. Achieving cholesterol goals. Current and future drug therapies. Jones PH Postgrad Med; 2003 Aug; 114(2 Suppl):14-21. PubMed ID: 19667635 [TBL] [Abstract][Full Text] [Related]
57. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study. Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548 [TBL] [Abstract][Full Text] [Related]
59. Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study. Ye X; Gross CR; Schommer J; Cline R; St Peter WL Clin Ther; 2007 Dec; 29(12):2748-57. PubMed ID: 18201593 [TBL] [Abstract][Full Text] [Related]